| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.29 | 6e-10 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |